On March 30, 2026, Solana Company (formerly Helius Medical Technologies, Inc.) released its financial results for the fourth quarter and full year ended December 31, 2025. The company reported a revenue of $5.2 million for Q4 2025, a significant increase from $0.2 million in the prior-year period, primarily driven by $5.1 million in staking rewards. However, the company faced substantial operational challenges, leading to total operating expenses of $206.1 million for the fourth quarter, compared to $3.1 million in the prior year. This included non-cash charges of $178.3 million for unrealized losses on digital assets. The net loss for Q4 2025 was reported at $40.9 million, or a loss of $4.25 per share, compared to a net loss of $3.9 million in the previous year. For the full year 2025, Solana Company generated $6.0 million in revenue, up from $0.5 million in 2024, but incurred a total operating loss of $243.8 million. The company’s cash position at year-end was $7.3 million, with digital assets valued at $293.7 million. Despite the challenges, the company remains focused on its digital asset treasury strategy and plans to continue its efforts to enhance shareholder value through various capital actions.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.